Article
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
The New England journal of medicine - 9 Oct 2003
Wilschanski Michael, Yahav Yaacov, Yaacov Yasmin, Blau Hannah, Bentur Lea, Rivlin Joseph, Aviram Micha, Bdolah-Abram Tali, Bebok Zsuzsa, Shushi Liat, Kerem Batsheva, Kerem Eitan
Abstract excerpt
BACKGROUND: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene containing a premature termination signal cause a deficiency or absence of functional chloride-channel activity. Aminoglycoside antibiotics can suppress premature termination codons, thus permitting translation to continue to the normal end of the transcript. We assessed whether topical administration of gentamicin to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
